Assessment of the severity of atopic dermatitis — SCORAD and EASI
- Authors: Karamova A.E.1, Chikin V.V.1, Znamenskaya L.F.1, Aulova K.M.1
-
Affiliations:
- State Research Center of Dermatovenereology and Cosmetology
- Issue: Vol 98, No 3 (2022)
- Pages: 53-60
- Section: GUIDELINES FOR PRACTITIONERS
- URL: https://journals.rcsi.science/0042-4609/article/view/117606
- DOI: https://doi.org/10.25208/vdv1335
- ID: 117606
Cite item
Full Text
Abstract
Atopic dermatitis is one of the most prevalent chronic inflammatory skin diseases, which can vastly influence the patients’ quality of life. Objective assessment of severity is required to select adequate therapy and evaluate its effectiveness. Heterogeneous clinical manifestations with greatly varying severity make it difficult to assess the severity of atopic dermatitis. More than twenty methods are developed for the assessment of this disease’s severity. SCORAD, oSCORAD and EASI are the most elementary and reliable methods allowing to define the severity of atopic dermatitis relatively quickly and accurately. Each of these three methods has its own particularities, that could be advantages or disadvantages depending on circumstances.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Arfenya E. Karamova
State Research Center of Dermatovenereology and Cosmetology
Email: karamova@cnikvi.ru
ORCID iD: 0000-0003-3805-8489
SPIN-code: 3604-6491
MD, Cand. Sci. (Med.)
Russian Federation, Korolenko str., 3, bldg 6, 107076, MoscowVadim V. Chikin
State Research Center of Dermatovenereology and Cosmetology
Email: chikin@cnikvi.ru
ORCID iD: 0000-0002-9688-2727
SPIN-code: 3385-4723
MD, Dr. Sci (Med.)
Russian Federation, Korolenko str., 3, bldg 6, 107076, MoscowLyudmila F. Znamenskaya
State Research Center of Dermatovenereology and Cosmetology
Author for correspondence.
Email: znaml@cnikvi.ru
ORCID iD: 0000-0002-2553-0484
SPIN-code: 9552-7850
MD, Dr. Sci. (Med.)
Russian Federation, Korolenko str., 3, bldg 6, 107076, MoscowKseniya M. Aulova
State Research Center of Dermatovenereology and Cosmetology
Email: aulovaksenia@mail.ru
ORCID iD: 0000-0002-3129-0050
SPIN-code: 8334-2890
medical resident
Russian Federation, Korolenko str., 3, bldg 6, 107076, MoscowReferences
- Кубанов А.А., Намазова-Баранова Л.С., Хаитов Р.М., Ильина Н.И., Алексеева Е.А., Амбарчян Э.Т., и др. Атопический дерматит. Российский Аллергологический Журнал. 2021;18(3):44–92. [Kubanov AA, Namazova-Baranova LS, Haitov RM, Il'ina NI, Alekseeva EA, Ambarchjan JeT, et al. Atopicheskij dermatit. Rossijskij Allergologicheskij Zhurnal. 2021;18(3):44–92 (In Russ.)]. doi: 10.36691/RJA1474
- Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018; 32(5): 657–682. doi: 10.1111/jdv.14891 Erratum in: J Eur Acad Dermatol Venereol. 2019; 33(7):1436.
- Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340–347. doi: 10.1016/j.anai.2018.07.006
- Dawn A, Papoiu AD, Chan YH, Rapp SR, Rassette N, Yosipovitch G. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol. 2009;160(3):642–644. doi: 10.1111/j.1365-2133.2008.08941.x
- Ahn C, Huang W. Clinical Presentation of Atopic Dermatitis. AdvExp Med Biol. 2017;1027:39–46. doi: 10.1007/978-3-319-64804-0_4
- Хаитов Р.М., Балаболкин И.И., Гущин И.С., Кубанова А.А., Астафьева Н.Г., Гребенюк В.Н., и др. Атопический дерматит: рекомендации для практических врачей. Под общей редакцией академика РАМН Р.М. Хаитова и члена-корреспондента РАМН, профессора А.А. Кубановой. Москва: «Фармарус Принт»; 2002. С. 5–6. [Haitov RM, Balabolkin II, Gushhin IS, Kubanova AA, Astaf'eva NG, Grebenjuk VN, et al. Atopicheskij dermatit: rekomendacii dlja prakticheskih vrachej. Pod obshhej redakciej akademika RAMN R.M. Haitova i chlena-korrespondenta RAMN, professora AA Kubanovoj. Moscow: “Farmarus Print”; 2002. Р. 5–6 (In Russ.)]
- Клинические рекомендации «Атопический дерматит». Год утверждения: 2021. Разработчик клинической рекомендации: Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов»; Российская ассоциация аллергологов и клинических иммунологов; Союз педиатров России; Союз «Национальный альянс дерматовенерологов и косметологов». Одобрено Научно-практическим Советом Минздрава РФ. [Klinicheskie rekomendacii “Atopicheskij dermatit”. God utverzhdenija: 2021. Razrabotchik klinicheskoj rekomendacii: Obshherossijskaja obshhestvennaja organizacija "Rossijskoe obshhestvo dermatovenerologov i kosmetologov"; Rossijskaja associacija allergologov i klinicheskih immunologov; Sojuz pediatrov Rossii; Sojuz “Nacional'nyj al'jans dermatovenerologov i kosmetologov”. Odobreno Nauchno-prakticheskim Sovetom Minzdrava RF (In Russ.)]
- Wittkowski A, Richards HL, Griffiths CE, Main CJ. Illness perception in individuals with atopic dermatitis. Psychol Health Med. 2007;12(4):433–444. doi: 10.1080/13548500601073928
- Стародубов В.И., Александрова Г.А., Богданова Е.В., Голубев Н.А., Мелехина Л.Е., Огрызко Е.В., и др. Ресурсы и деятельность медицинских организаций дерматовенерологического профиля. Заболеваемость инфекциями, передаваемыми половым путем, заразными кожными болезнями и заболеваниями кожи за 2019–2020 гг. Статистические материалы. М.: Департамент мониторинга, анализа и стратегического развития здравоохранения Минздрава России, ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения» Минздрава России, ФГБУ «Государственный научный центр дерматовенерологии и косметологии» Минздрава России, 2021. Доступно по: Медицинская статистика (mednet.ru). [Starodubov VI, Alexandrova GA, Bogdanova EV, Golubev NA, Melekhina LE, Ogryzko EV, et al. Resources and performance of dermatovenerologicalmedicalorganizations. The incidence of sexually transmitted infections, infectious skin diseases and skin diseases in 2019–2020. Statistical materials. Moscow: Department of Monitoring, Analysis and Strategic Development of Healthcare of the Ministry of Health of Russia, Federal State Budgetary Institution "Central Research Institute for Organization and Informatization of Healthcare" of the Ministry of Health of Russia, Federal State Budgetary Institution "State Scientific Center for Dermatovenereology and Cosmetology" of the Ministry of Health of Russia, 2021. Available at: Medicinskaja statistika (mednet.ru) (In Russ.)]
- Schmitt J, Spuls PI, Thomas KS, Simpson E, Furue M, Deckert S, et al. HOME initiative collaborators. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol. 2014;134(4):800–807. doi: 10.1016/j.jaci.2014.07.043
- Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol. 2003;120(6):932–941. doi: 10.1046/j.1523-1747.2003.12251.x
- Schmitt J, Langan S, Williams HC. European Dermato-Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol. 2007;120(6):1389–1398. doi: 10.1016/j.jaci.2007.08.011
- Rehal B, Armstrong AW. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985–2010. PLoS One. 2011;13;6(4):17520. doi: 10.1371/journal.pone.0017520 Erratum in: PLoS One. 2011;6(6):10.1371/annotation/6d5e99c5-bd8f-4cef-b77a-fbb795633da0. Armstrong, April [Corrected to Armstrong, April W]
- Oranje AP. Practical issues on interpretation of scoring atopic dermatitis: SCORAD Index, objective SCORAD, patient-oriented SCORAD and Three-Item Severity score. Curr Probl Dermatol. 2011;41:149–155. doi: 10.1159/000323308
- Oranje AP, Stalder JF, Taïeb A, Tasset C, de Longueville M. Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study Group. Early Treatment of the Atopic Child. Pediatr Allergy Immunol. 1997;8(1):28–34. doi: 10.1111/j.1399-3038.1997.tb00139.x
- European Task Force on Atopic Dermatitis: Severity scoring of atopic dermatitis: the SCORAD index — consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23–31.
- Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen JP, de Bruin-Weller M, et al. European Task Force on Atopic Dermatitis/EADV Eczema Task Force. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol. 2020;34(12):2717–2744. doi: 10.1111/jdv.16892
- Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10–19. doi: 10.1159/000245677
- Thomas KS, Apfelbacher CA, Chalmers JR, Simpson E, Spuls PI, Gerbens LAA, et al. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting. Br J Dermatol. 2020. doi: 10.1111/bjd.19673
- Oakley A. EASI score. https://dermnetnz.org/topics/easi-score (2015)
- Leshem YA, Hajar T, Hanifin JM, Simpson EL. What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study. Br J Dermatol. 2015;172(5):1353–1357. doi: 10.1111/bjd.13662
- Chopra R, Vakharia PP, Sacotte R, Patel N, Immaneni S, White T, et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017;177(5):1316–1321. doi: 10.1111/bjd.15641
- Wollenberg A, Oranje A, Deleuran M, Simon D, Szalai Z, Kunz B, et al. European Task Force on Atopic Dermatitis/EADV Eczema Task Force. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol. 2016;30(5):729–747. doi: 10.1111/jdv.13599
- Chopra R, Vakharia PP, Sacotte R, Patel N, Immaneni S, White T, et al. Relationship between EASI and SCORAD severity assessments for atopic dermatitis. J Allergy Clin Immunol. 2017;140(6):1708-1710.e1. doi: 10.1016/j.jaci.2017.04.052
- Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K, et al. Harmonising Outcome Measures for Atopic Dermatitis (HOME) Initiative. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol. 2013;132(6):1337–1347. doi: 10.1016/j.jaci.2013.07.008
- Chopra R, Silverberg JI. Assessing the severity of atopic dermatitis in clinical trials and practice. Clin Dermatol. 2018;36(5):606–615. doi: 10.1016/j.clindermatol.2018.05.012
Supplementary files
